Table 3 Number of emergency admissions by tumour site between the pre-COVID (2017–2019) and during COVID (2020) cohorts
From: Impact of the COVID-19 pandemic on emergency hospital cancer admissions in a UK region
Tumour Site and ICD10 code | Patient Cohorts | Percentage Change in Admissions from Pre-COVID to During COVID | Binomial Probability Test Results (95% Confidence Intervals) | |
|---|---|---|---|---|
Pre-COVID (2017–2019 Average) | During COVID (2020) | |||
Brain and CNS (C70–72, C75·1–75·3, D32–33, D35·2–35·4, D42–43, D44·3–44·5) | 204 (5·9%) | 147 (4·9%) | - 27·9% | p < 0·001, 19·2% (16·5% to 22·2%) |
Breast (C50) | 72 (2·1%) | 53 (1·7%) | - 26·4% | p = 0·024, 19·7% (15·1% to 25·0%) |
Colorectal (C18–20) | 331 (9·6%) | 285 (9·4%) | - 13·9% | p = 0·013, 22·3% (20·0% to 24·7%) |
Female Genitalia (C53–56) | 108 (3·1%) | 81 (2·7%) | - 25·0% | p = 0·011, 20·0% (16·2% to 24·3%) |
Haematological (C81–86, C90–95) | 505 (14·6%) | 431 (14·2%) | - 14·7% | p = 0·001, 22·1% (20·3% to 24·1%) |
Head and Neck (C00–14, C30–32) | 106 (3·1%) | 77 (2·5%) | - 27·4% | p = 0·005, 19·5% (15·7% to 23·8%) |
Liver (C22) | 99 (2·9%) | 107 (3·5%) | + 8·1% | p = 0·782, 26·6% (22·3% to 31·2%) |
Lung (C33–34) | 540 (15·6%) | 463 (15·3%) | - 14·3% | p = 0·001, 22·2% (20·5% to 24·1%) |
Male Genitalia (C61, C63) | 101 (2·9%) | 80 (2·6%) | - 20·8% | p = 0·036, 20·9% (17·0% to 25·4%) |
Other (all other ‘C’ codes) | 206 (6·0%) | 193 (6·4%) | - 6·3% | p = 0·221, 23·8% (20·9% to 26·9%) |
Pancreas (C25) | 150 (4·3%) | 150 (5·0%) | 0·0% | p = 0·513, 25·0% (21·6% to 28·6%) |
Skin (C43–44) | 27 (0·8%) | 25 (0·8%) | - 7·4% | p = 0·397, 23·4% (15·7% to 32·5%) |
Unknown Primary (C77–80) | 677 (19·6%) | 635 (21·0%) | - 6·2% | p = 0·081, 23·8% (22·2% to 25·5%) |
Upper GI Tract(C15–16) | 202 (5·9%) | 204 (6·7%) | + 1·0% | p = 0·567, 25·2% (22·3% to 28·3%) |
Urinary Tract (C64–68) | 124 (3·6%) | 98 (3·2%) | - 21·0% | p = 0·019, 20·8% (17·2% to 24·8%) |
Total | 3452 (100%) | 3029 (100%) | - 12·3% | |